Showing 35,661 results

Filters
Injectable & long-acting PrEP

AIDS 2026: Roll-out of lencapavir PrEP Video

August 2026
Economic & social inequality

AIDS 2026: Racism and health Video

August 2026
Liver disease

Lean people with HIV can still develop fatty liver disease

News
7 August 2026
The search for a cure

A new class of drugs could sharpen the body’s immune response to HIV

News
7 August 2026
Economic & social inequality

Racism remains a central driver of global HIV epidemics

News
7 August 2026
Employment

North Korea expands mandatory HIV testing to service workers

Editor's pick
Daily NK
7 August 2026
Chemsex & recreational drug use

Chemsex is everywhere, but often invisible and unaddressed

News
7 August 2026
Sexually transmitted infections prevention

DoxyPEP linked to reduction in syphilis and chlamydia among gay men in Australia

News
7 August 2026
People & personal stories

‘The boy who wanted a cure’: How Kenyan scientist became a global HIV leader

Editor's pick
Daily Nation
6 August 2026
The search for a cure

Could leronlimab, a CCR5 blocker, be used to facilitate stem-cell transplant cures of HIV?

News
6 August 2026
Low CD4 count

Returning to HIV care does not erase the effects of treatment interruption, studies show

News
6 August 2026

AIDS 2026: Racism remains a central driver of global HIV epidemics, 6 August 2026

August 2026
New & experimental HIV treatments

AIDS 2026: ART pipeline and new drugs

Editor's pick
i-Base
5 August 2026
Injectable & long-acting PrEP

Cabotegravir HIV PrEP Effective Among U.S. Women Despite Treatment Interruptions

Editor's pick
MedPage Today (requires free registration)
5 August 2026
Heterosexual men

Mobile Men study: injectable PrEP beats pills for men who travel for work

Editor's pick
Africa Health Research Institute
5 August 2026
Access to healthcare

Lenacapavir, the revolutionary HIV drug, still hasn’t reached Latin America

Editor's pick
El País
5 August 2026
Antibody-based prevention

As a weekly anti-HIV pill nears the market, vaccine research faces new hurdles

Editor's pick
Science
5 August 2026
Migrants, refugees & displaced people

Zimbabweans Fleeing Xenophobia in South Africa Battle to Get HIV Medicine Back Home

Editor's pick
Health Policy Watch
5 August 2026
Injectable & long-acting PrEP

Gilead’s HIV PrEP franchise hits $1B quarterly sales, but analysts question Yeztugo durability

Editor's pick
FiercePharma
5 August 2026
Activism & civil society

Advocates fight back: HIVMA members on the front lines of Florida’s ADAP crisis

Editor's pick
IDSA
5 August 2026
Low CD4 count

Enhanced access to diagnostic screening improves care for advanced HIV

News
4 August 2026

AIDS 2026: Two more HIV cures after stem cell transplants offer new clues, 3 August 2026

August 2026
Government, leadership & policy

Canada Has Everything It Needs to End HIV. So Why Are Rates Rising Among Young Gay Men?

Editor's pick
Uncloseted Media
3 August 2026
Access to healthcare

South Africa: Some pieces falling into place for monthly HIV prevention pill, but key data not yet in

Editor's pick
Spotlight
2 August 2026